Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer-Reference-Cited by-同舟云学术

Intratumoural immunotherapy plus focal thermal ablation for localized prostate cancer

Published:2023-12-19 Issue: Volume: Page:
ISSN:1759-4812
Container-title:Nature Reviews Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Séguier Denis,Adams Eric S.^ORCID,Kotamarti Srinath,D’Anniballe Vincent,Michael Zoe D.^ORCID,Deivasigamani Sriram,Olivier Jonathan,Villers Arnauld,Hoimes Christopher,Polascik Thomas J.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://www.nature.com/articles/s41585-023-00834-y.pdf

Reference121 articles.

1. Carlino, M. S., Larkin, J. & Long, G. V. Immune checkpoint inhibitors in melanoma. Lancet 398, 1002–1014 (2021).

2. Kartolo, A., Kassouf, W. & Vera-Badillo, F. E. Adjuvant immune checkpoint inhibition in muscle-invasive bladder cancer: is it ready for prime time? Eur. Urol. 80, 679–681 (2021).

3. Handy, C. E. & Antonarakis, E. S. Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions. Future Oncol. 14, 907–917 (2018).

4. Antonarakis, E. S. et al. Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study. J. Clin. Oncol. 38, 395–405 (2020).

5. Nair, S. S., Weil, R., Dovey, Z., Davis, A. & Tewari, A. K. The tumor microenvironment and immunotherapy in prostate and bladder cancer. Urol. Clin. North. Am. 47, e17–e54 (2020).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10

2. Precise Regulation of Reactive Oxygen Species in Tumor Microenvironment for Alleviating Inhibitory Immunogenic Cell Death;Advanced Healthcare Materials;2024-08-07

3. Unveiling the Genomic Landscape of Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis;International Journal of Molecular Sciences;2024-04-28

4. A novel prognosis and drug-susceptibility predictor based inflammatory-related genes signature in prostate cancer;Journal of Men's Health;2024

5. Irreversible Electroporation Combined with PD-L1/IL-6 Dual Blockade Promotes Anti-Tumor Immunity via cDC2/CD4 T Cell Axis in MHC-I Deficient Pancreatic Cancer;2024